(PubMed) Benton D, Fordy J, Haller J
Because Melanotan stimulates pigment-producing cells, case reports have documented darkening of existing moles and the appearance of new pigmented lesions in people using it, along with reports of melanoma diagnosed in users
Figure 3B shows network estimates of treatment effect on Hb levels for different administration routes compared to the oral route
1 ) , and therefore inhibiting IRE1 activity has consequences for both branches of UPR, which makes targeting IRE1 in anticancer therapies quite challenging (Martinez-Turtos et al
However, these observations have not been confirmed in large-scale human trials
Light is the main risk factor and UV light will destabilise them - but how quickly I don't know